Issue 17, 2021

Aminocellulose - grafted polycaprolactone-coated core–shell nanoparticles alleviate the severity of ulcerative colitis: a novel adjuvant therapeutic approach

Abstract

Ulcerative colitis (UC) is an idiopathic inflammatory condition of colorectal regions. Existing therapies for UC face grave lacunae including off-target and other harmful side effects, extensive first-pass metabolism, rapid clearance, limited or poor drug absorption and various other limitations, resulting in lower bioavailability. These conditions demand advanced delivery strategies to inflammatory colonic conditions so that drugs can counter stomach acid, avail protective strategies at this pH and selectively deliver drugs to the colon. Therefore, this approach was undertaken to develop and characterize nanoparticles for the delivery of drugs glycyrrhizic acid as well as budesonide in UC. Biocompatible and biodegradable aminocellulose-conjugated polycaprolactone containing budesonide was covered onto gelatinous nanoparticles (NPs) loaded with GA. Nanoparticles were prepared by the solvent evaporation technique, which showed particle size of ∼230 nm, spherical shape, almost smooth morphological characters under transmission, scanning and atomic force microscopy. These NPs also improved disease activities like occult blood in the stool, length of the colon and fecal properties. The nanoparticle therapy appreciably decreased colonic mast cellular infiltration, significantly maintained mucin protection, ameliorated histological features of the colon. Furthermore, markers of inflammation such as iNOS, COX-2, IL1-β, TNF-α, NO, and MPO were also appreciably ameliorated with the therapy of dual drug-loaded nanoparticles. Overall, these results establish that dual drug-loaded core–shell NPs exhibit superior therapeutic properties over the free or naïve forms of GA and budesonide in acute colon inflammation and present advantages that may be assigned to their ability to significantly inhibit colon inflammatory conditions.

Graphical abstract: Aminocellulose - grafted polycaprolactone-coated core–shell nanoparticles alleviate the severity of ulcerative colitis: a novel adjuvant therapeutic approach

Supplementary files

Article information

Article type
Paper
Submitted
06 Jun 2021
Accepted
21 Jun 2021
First published
02 Jul 2021

Biomater. Sci., 2021,9, 5868-5883

Aminocellulose - grafted polycaprolactone-coated core–shell nanoparticles alleviate the severity of ulcerative colitis: a novel adjuvant therapeutic approach

A. Ahmad, Md. M. Ansari, A. Kumar, M. Bishnoi, S. S. Raza and R. Khan, Biomater. Sci., 2021, 9, 5868 DOI: 10.1039/D1BM00877C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements